✦ LIBER ✦

18: Sirolimus as Primary Immunosuppressant Attenuates Left Ventricular Hypertrophy and Improves Diastolic Function in Cardiac Transplant Recipients

✍ Scribed by E. Raichlin; K. Chandrasekaran; K.K. Walter; A.L. Clavell; R.J. Rodheffer; N.L. Pereira; R.P. Frantz; J.A. Wagner; C.C. McGregor; R.C. Daly; B.S. Edwards; S.S. Kushwaha

Book ID: 116520326
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 27
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2007.11.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

54 Utilization of Sirolimus as Primary I

54 Utilization of Sirolimus as Primary Immunosuppression Attenuates Cardiac Allograft Vasculopathy and Improves Late Survival in the Heart Transplant Population

✍ Y. Topilsky; E. Raichlin; B.A. Boilson; J.A. Schirger; N.L. Pereira; B.S. Edward 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 171 KB

52: Sirolimus as Primary Immunosupressio

52: Sirolimus as Primary Immunosupression Is Associated with Improved Renal Function and Survival Compared with Calcineurin Inhibitors in Stable Cardiac Transplant Recipients

✍ M.A. Al-Omari; E. Raichlin; N.L. Pereira; B.S. Edwards; A.L. Clavell; R.J. Rodeh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB